Expression of SMADs in orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine model

Activin A promotes the development of endometriotic lesions in a murine model of endometriosis, and the immunohistochemical localization of phosphorylated suppressor of mothers against decapentaplegic homolog 2/3 (pSMAD2/3) complex in endometriotic lesions has been reported. Activin may therefore be...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuri Kadota, Takeshi Kato, Kana Kasai, Takako Kawakita, Misaki Murayama, Akari Shinya, Hikari Sasada, Sachiko Katayama, Mari Nii, Shota Yamamoto, Hiroki Noguchi, Kou Tamura, Hidenori Aoki, Miyu Taniguchi, Tomotaka Nakagawa, Takashi Kaji, Masato Nishimura, Riyo Kinouchi, Kanako Yoshida, Takeshi Iwasa
Format: Article
Language:English
Published: The Japan Endocrine Society 2024-04-01
Series:Endocrine Journal
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/endocrj/71/4/71_EJ23-0486/_html/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591678536417280
author Yuri Kadota
Takeshi Kato
Kana Kasai
Takako Kawakita
Misaki Murayama
Akari Shinya
Hikari Sasada
Sachiko Katayama
Mari Nii
Shota Yamamoto
Hiroki Noguchi
Kou Tamura
Hidenori Aoki
Miyu Taniguchi
Tomotaka Nakagawa
Takashi Kaji
Masato Nishimura
Riyo Kinouchi
Kanako Yoshida
Takeshi Iwasa
author_facet Yuri Kadota
Takeshi Kato
Kana Kasai
Takako Kawakita
Misaki Murayama
Akari Shinya
Hikari Sasada
Sachiko Katayama
Mari Nii
Shota Yamamoto
Hiroki Noguchi
Kou Tamura
Hidenori Aoki
Miyu Taniguchi
Tomotaka Nakagawa
Takashi Kaji
Masato Nishimura
Riyo Kinouchi
Kanako Yoshida
Takeshi Iwasa
author_sort Yuri Kadota
collection DOAJ
description Activin A promotes the development of endometriotic lesions in a murine model of endometriosis, and the immunohistochemical localization of phosphorylated suppressor of mothers against decapentaplegic homolog 2/3 (pSMAD2/3) complex in endometriotic lesions has been reported. Activin may therefore be involved in the development and proliferation of endometriotic cells via the SMAD signaling pathway. However, few detailed reports exist on SMAD7 expression in endometriosis. The purpose of this study was to investigate the expression of pSMAD2/3 or pSMAD3 and SMAD7 in the orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine model and the effect of activin A on pSMAD2/3 and SMAD7 expression. We established an endometriosis murine model via the intraperitoneal administration of endometrial tissue and blood from donor mice. Activin A was intraperitoneally administered to the activin group. We immunohistochemically evaluated orthotopic endometria, ovarian endometriotic tissues, and endometriotic lesions in the murine model followed by western blotting. We found that pSMAD3 and SMAD7 were expressed in ovarian endometriosis and orthotopic endometria from patients with and without endometriosis. In the murine model, endometriotic lesions expressed pSMAD2/3 and SMAD7 in the activin and control groups, and higher SMAD7 expression was found in the activin group. To the best of our knowledge, this study is the first to show that SMAD7 expression is upregulated in endometriosis. In conclusion, these results suggest that activin A activates the SMAD signaling pathway and promotes the development of endometriotic lesions, thus identifying SMAD7 as a potential therapeutic target for endometriosis.
format Article
id doaj-art-18d6b2144fed4703917247ed7535ca31
institution Kabale University
issn 1348-4540
language English
publishDate 2024-04-01
publisher The Japan Endocrine Society
record_format Article
series Endocrine Journal
spelling doaj-art-18d6b2144fed4703917247ed7535ca312025-01-22T06:37:03ZengThe Japan Endocrine SocietyEndocrine Journal1348-45402024-04-0171439540110.1507/endocrj.EJ23-0486endocrjExpression of SMADs in orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine modelYuri Kadota0Takeshi Kato1Kana Kasai2Takako Kawakita3Misaki Murayama4Akari Shinya5Hikari Sasada6Sachiko Katayama7Mari Nii8Shota Yamamoto9Hiroki Noguchi10Kou Tamura11Hidenori Aoki12Miyu Taniguchi13Tomotaka Nakagawa14Takashi Kaji15Masato Nishimura16Riyo Kinouchi17Kanako Yoshida18Takeshi Iwasa19Department of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanDepartment of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503, JapanActivin A promotes the development of endometriotic lesions in a murine model of endometriosis, and the immunohistochemical localization of phosphorylated suppressor of mothers against decapentaplegic homolog 2/3 (pSMAD2/3) complex in endometriotic lesions has been reported. Activin may therefore be involved in the development and proliferation of endometriotic cells via the SMAD signaling pathway. However, few detailed reports exist on SMAD7 expression in endometriosis. The purpose of this study was to investigate the expression of pSMAD2/3 or pSMAD3 and SMAD7 in the orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine model and the effect of activin A on pSMAD2/3 and SMAD7 expression. We established an endometriosis murine model via the intraperitoneal administration of endometrial tissue and blood from donor mice. Activin A was intraperitoneally administered to the activin group. We immunohistochemically evaluated orthotopic endometria, ovarian endometriotic tissues, and endometriotic lesions in the murine model followed by western blotting. We found that pSMAD3 and SMAD7 were expressed in ovarian endometriosis and orthotopic endometria from patients with and without endometriosis. In the murine model, endometriotic lesions expressed pSMAD2/3 and SMAD7 in the activin and control groups, and higher SMAD7 expression was found in the activin group. To the best of our knowledge, this study is the first to show that SMAD7 expression is upregulated in endometriosis. In conclusion, these results suggest that activin A activates the SMAD signaling pathway and promotes the development of endometriotic lesions, thus identifying SMAD7 as a potential therapeutic target for endometriosis.https://www.jstage.jst.go.jp/article/endocrj/71/4/71_EJ23-0486/_html/-char/enendometriosissuppressor of mothers against decapentaplegic (smad)suppressor of mothers against decapentaplegic 7 (smad7)activin a
spellingShingle Yuri Kadota
Takeshi Kato
Kana Kasai
Takako Kawakita
Misaki Murayama
Akari Shinya
Hikari Sasada
Sachiko Katayama
Mari Nii
Shota Yamamoto
Hiroki Noguchi
Kou Tamura
Hidenori Aoki
Miyu Taniguchi
Tomotaka Nakagawa
Takashi Kaji
Masato Nishimura
Riyo Kinouchi
Kanako Yoshida
Takeshi Iwasa
Expression of SMADs in orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine model
Endocrine Journal
endometriosis
suppressor of mothers against decapentaplegic (smad)
suppressor of mothers against decapentaplegic 7 (smad7)
activin a
title Expression of SMADs in orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine model
title_full Expression of SMADs in orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine model
title_fullStr Expression of SMADs in orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine model
title_full_unstemmed Expression of SMADs in orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine model
title_short Expression of SMADs in orthotopic human endometrium, ovarian endometriosis, and endometriotic lesions in a murine model
title_sort expression of smads in orthotopic human endometrium ovarian endometriosis and endometriotic lesions in a murine model
topic endometriosis
suppressor of mothers against decapentaplegic (smad)
suppressor of mothers against decapentaplegic 7 (smad7)
activin a
url https://www.jstage.jst.go.jp/article/endocrj/71/4/71_EJ23-0486/_html/-char/en
work_keys_str_mv AT yurikadota expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT takeshikato expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT kanakasai expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT takakokawakita expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT misakimurayama expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT akarishinya expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT hikarisasada expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT sachikokatayama expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT marinii expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT shotayamamoto expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT hirokinoguchi expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT koutamura expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT hidenoriaoki expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT miyutaniguchi expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT tomotakanakagawa expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT takashikaji expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT masatonishimura expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT riyokinouchi expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT kanakoyoshida expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel
AT takeshiiwasa expressionofsmadsinorthotopichumanendometriumovarianendometriosisandendometrioticlesionsinamurinemodel